Receiver operating characteristic analysis indicated that the AUC values of versican in both plasma and exosomes exceeded those of traditional markers, such as NSE, CYFRA21-1, and SCCA, indicating superior diagnostic efficacy in NSCLC (166). The gene discussed is VCAN; the disease is non-small cell lung carcinoma.